HOME >> BIOLOGY >> NEWS
Two Sandia microChemLab technologies soon to be checking for toxins in the nation's water supplies

ALBUQUERQUE, N.M. -- Two technologies developed at the National Nuclear Security Administration's Sandia National Laboratories are expected to soon be checking for toxins and harmful bacteria in the nation's water supplies. Both are based on the microChemLab.

The microChemLab, officially called microChemLab, is a hand-held "chemistry laboratory." The liquid prototype was designed and built at Sandia/California, while the microChemLab that takes measurements in the gas phase was developed at Sandia/New Mexico.

Complete with the microChemLab, electronics, and sample collector, both devices weigh about 25 pounds and fit into a box the size of a small suitcase. The only external parts of the two sensor technologies are water collectors. The units are completely portable.

"Our goal is to place these sensors within utility water systems and use them to quickly determine if the water contains harmful bacteria and toxins," says Wayne Einfeld, who heads the Sensor Development Focus Area within Sandia's Water Initiative (www.sandia.gov/water). "This on-site monitoring approach would enhance current utility monitoring systems that require water samples to be sent to laboratories for analysis, which sometimes takes days for results."

The United States has more than 300,000 public supply water wells, 55,000 utilities, 120,000 transient systems at rest stops or campgrounds, and tens of millions of hydrants. Up until now, real-time, remote water quality monitoring for toxins has been very limited.

The liquid microChemLab is currently being tested at the Contra Costa (Calif.) Water District, says Jay West, California principal investigator. Specifically, the team is testing to determine the steps necessary to identify toxins in drinking water, as well as expanding its capabilities as an autonomous monitor. The device is presently collecting and analyzing a water sample every 30 minutes and reporting results via a real-time data link to resear
'"/>

Contact: Chris Burroughs
coburro@sandia.gov
505-844-0948
DOE/Sandia National Laboratories
27-Sep-2005


Page: 1 2 3 4

Related biology news :

1. Sandia researchers take new approach to studying how cells respond to pathogens
2. Sandia research to focus on early detection of harmful algal blooms
3. Sandia researchers discover way to see how a drug attaches to a cell
4. Sandia National Laboratories and Monsanto Company announce cooperative research agreement
5. Sandia tool speeds up environmental cleanup, reopening of contaminated facilities
6. Sandia researchers to study techniques for arsenic removal from drinking water
7. Argonne wins three R&D 100 awards for innovative technologies
8. Does EPA have an adequate strategy to oversee nanotechnologies?
9. A new report, Where Does the Nano Go? End-of-Life Regulation of Nanotechnologies
10. Combining molecular imaging technologies to stop/prevent heart attacks
11. Fusing imaging technologies creates synergy, helps diagnose heart disease accurately

Post Your Comments:
(Date:10/30/2014)... therapeutics present unique challenges when it comes to ... harm. New consensus guidelines for toxicity testing that ... characteristics of these novel biopharmaceuticals are presented in ... from Mary Ann Liebert, Inc. publishers . ... Nucleic Acid Therapeutics website until November 30, ...
(Date:10/30/2014)... Oct. 29, 2014  Securus Technologies, a ... technology solutions for public safety, investigation, corrections ... deployed exciting enhancements to its THREADS™ product, ... provide actionable intelligence and focused leads for ... drive technological innovation through identifying and delivering ...
(Date:10/29/2014)... Beaverton, OR) New research presented at the ... in Houston, TX showed for the first time ... in women using a readily available nutritional supplement, ... by Dr. Judith A. Smith, Pharm.D., associate professor ... Sciences at The University of Texas Health Science ...
Breaking Biology News(10 mins):New guidelines for reproductive & developmental toxicity testing of oligonucleotide drugs 2Securus Technologies Adds Advanced Features to Its Industry-Leading Investigative Analytics Product 2HPV infections in women eradicated by AHCC, Japanese mushroom extract 2
(Date:10/30/2014)... , Oct. 30, 2014  Regado Biosciences, Inc. ... will hold a conference call and live audio webcast ... to discuss its third quarter 2014 financial results. ... call by dialing (888) 347-1165 for domestic callers or ... be webcast live under the investor relations section of ...
(Date:10/30/2014)... (Oct. 29, 2014) – The severe flooding that devastated ... been less destructive if the bridges, roads and other ... new study from the University of Colorado Denver. , ... infrastructure," said Jimmy Kim, PhD, associate professor of structural ... Applied Science and lead author the study. "There is ...
(Date:10/27/2014)... October 27, 2014 The new ... Type (High & Medium), Sub-type (Primary & Secondary), ... Infrastructure & Transportation & Power Generation) - Trends ... GIS market with analysis and forecasting of the ... Data Tables with 52 Figures spread through 146 ...
(Date:10/27/2014)... TORONTO , Oct. 27, 2014 ... (OTCQB: GNBT) today announced two presentations demonstrating that ... its novel proprietary cancer immunotherapeutic AE37 vaccine correlated ... patients. The AE37 cancer vaccine is being developed ... ( www.antigenexpress.com ). The presentations are being made ...
Breaking Biology Technology:Regado Biosciences to Provide Third Quarter 2014 Financial Results 2CU Denver study says upgrading infrastructure could reduce flood damage 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 2Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 3Gas Insulated Switchgear Market worth $21,951.9 Million by 2019 - New Report by MarketsandMarkets 4Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 2Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 3Generex Announces Presentations Correlating Immunological Response with Reduced Recurrence in Phase II Study of AE37 Breast Cancer Vaccine in Patients at the American College of Surgeons 4
Cached News: